Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 723 across all filing types
Latest filing 2026-06-09 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document is a compliance disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30, notifying the stock exchanges of a newspaper advertisement of the 21st Annual General Meeting notice and e-voting information. It does not contain the AGM materials themselves or financial data, nor is it a US‐style proxy statement. It is a general regulatory announcement to the exchanges, so it falls under the fallback category “Regulatory Filings (RNS).”
2026-06-09 English
Please see annexed enclosure.
Regulatory Filings Classification · 80% confidence The document is a compliance announcement under SEBI LODR Regulation 30 informing the stock exchanges that a newspaper advertisement for the 21st Annual General Meeting notice and e-voting information has been published. It does not contain substantive AGM materials or vote results, nor is it the AGM notice or proxy statement itself—rather it is a regulatory disclosure. This falls under the general regulatory announcements category.
2026-06-09 English
Please see annexed enclosure.
Regulatory Filings Classification · 90% confidence The document is a stock exchange filing under SEBI LODR Regulation 30 notifying the schedule of an analyst/institutional investor meeting. It is a routine regulatory disclosure rather than a full financial report, earnings release, presentation, or other specific categories. It fits the ‘Regulatory Filings’ (RNS) fallback for miscellaneous compliance announcements.
2026-06-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 69% confidence The document is an exchange filing under SEBI LODR Regulation 30 notifying the schedule of an analyst/institutional investor meeting. It does not contain financial results, ESG information, or a detailed investor presentation; it is simply a regulatory announcement to stock exchanges. This falls under the general regulatory filings category.
2026-06-08 English
Please see annexed enclosure.
Report Publication Announcement Classification · 88% confidence The document is a formal disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 sent to BSE/NSE, notifying that the Integrated Annual Report for FY 2025-26 has been published and providing a web-link to access it. It does not contain the actual report or financial data, but simply announces the availability of the report. Under the “menu vs meal” rule, this is an announcement of a report publication, not the report itself. Therefore, the correct classification is Report Publication Announcement (RPA).
2026-06-08 English
General Updates
Report Publication Announcement Classification · 92% confidence The document is a letter under SEBI Listing Regulations notifying stakeholders of the web-link and path to access the Company’s Integrated Annual Report for FY 2025–26. It does not contain any substantive financial data or the report itself; rather, it announces publication and provides a link. Per the “menu vs meal” rule and definition, this is a Report Publication Announcement (RPA).
2026-06-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.